The knockdown of endogenous replication factor C4 decreases the growth and enhances the chemosensitivity of hepatocellular carcinoma cells
- 12 December 2008
- journal article
- research article
- Published by Wiley in Liver International
- Vol. 29 (1), 55-62
- https://doi.org/10.1111/j.1478-3231.2008.01792.x
Abstract
To identify differentially expressed genes and thereby detect potential molecular targets for future therapies directed against hepatocellular carcinoma (HCC).To isolate differentially expressed genes between HCC and adjacent non-cancerous liver tissues, cDNA microarray and quantitative reverse transcriptase polymerase chain reaction analyses were performed. Gene knockdown experiments in HepG2 cells were also performed using small interfering RNAs (siRNAs). Proteins were detected by immunostaining, and cell proliferation was analysed using the MTT/WST-8 assay. Apoptosis and cell cycle analyses were performed using flow cytometry.After an intensive screening for differentially expressed genes in HCC tissues, we isolated 23 upregulated genes in these lesions. Among these, we focused on the replication factor C4 (RFC4) gene. The expression of endogenous RFC4 proteins in HepG2 cells was found to be significantly reduced by RFC4-specific siRNA. This inhibition of RFC4 expression correlated with a decrease in cellular proliferation, increased levels of apoptosis and a sensitizing of the cells to the DNA-damaging chemotherapeutic agents, doxorubicin and camptothecin.The replication factor C4 gene may be a novel target for developing cancer therapeutics, which can enhance the antitumour activity of chemotherapeutic agents that induce DNA damage.This publication has 25 references indexed in Scilit:
- Prognostic molecular markers in hepatocellular carcinoma: A systematic reviewEuropean Journal of Cancer, 2007
- Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinomaEuropean Journal of Cancer, 2007
- Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: Identification of candidate amplified and overexpressed genesGenes, Chromosomes and Cancer, 2007
- Gene Expression Differences Associated with Human Papillomavirus Status in Head and Neck Squamous Cell CarcinomaClinical Cancer Research, 2006
- Apoptosis AssaysPublished by Springer Science and Business Media LLC ,2006
- Transformation‐associated gene regulation by ATF6α during hepatocarcinogenesisFEBS Letters, 2005
- Stem-like Cells in Human HepatoblastomaJournal of Histochemistry & Cytochemistry, 2004
- Rfc4 Interacts with Rpa1 and Is Required for Both DNA Replication and DNA Damage Checkpoints in Saccharomyces cerevisiaeMolecular and Cellular Biology, 2001
- Immunohistochemical detection of proliferating cell nuclear antigen in hepatocellular carcinoma: Relationship to histological gradeJournal of Gastroenterology and Hepatology, 1993
- Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinomaJournal of Medical Virology, 1990